{"id":"https://genegraph.clinicalgenome.org/r/b1c19e4a-2e06-42d3-bdd6-72750aca2793v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between the FUCA1 gene and fucosidosis, an autosomal recessive lysosomal storage disorder, was evaluated using the ClinGen Clinical Validity Framework as of July 27, 2022. FUCA1 encodes alpha-L-fucosidase, a lysosomal enzyme involved in the degradation of fucose-containing glycoproteins and glycolipids via cleaving via hydrolyzing alpha-fucose moieties at the non-reducing terminus of oligosaccharides (PMID: 2803312). Among patients with fucosidosis, alpha-fucosidase deficiency results in the accumulation of fucose-containing glycoproteins and glycolipids in multiple tissues (PMID: 4172303, PMID: 4241464). \n\nThe disease mechanism of fucosidosis is loss of function. Fucosidosis was first reported in 1968 by Van Hoof and Hers (PMID: 4172303) and the first report of biallelic variants in FUCA1 among patients with fucosidosis in 1989 by Kretz (PMID: 2642067). Both case-level (genetic) and experimental evidence support the relationship between FUCA1 and fucosidosis. Reported causal variants include missense, nonsense, frameshift, and splice-altering variants (PMID: 33266441, PMID: 2642067, PMID: 1281988, PMID: 8097260, PMID: 8401503, PMID: 8401503, PMID: 9039984, PMID: 8081399). In total, eight variants from seven probands in six publications were curated. Although there is additional published case-level evidence available, the maximum score for genetic evidence (12 points) has already been reached. \n\nExperimental evidence for the relationship between FUCA1 and fucosidosis includes: the biochemical function of the gene product (alpha-fucosidase) being consistent with the clinical and biochemical findings identified individuals with fucosidosis (PMID: 4172303, PMID: 4241464); the biochemical and clinical features of FUCA1 knockout mice (PMID: 27491075); and rescue of alpha-fucosidase enzyme function via hematopoietic cell transplantation in a patient with fucosidosis (PMID: 11360116). Additional experimental evidence is available, but the maximum score for experimental evidence (6 points) has already been reached.\n\nIn sum, FUCA1 is definitively associated with fucosidosis. The association has been repeatedly demonstrated in both clinical and research settings, and has been upheld over time. This clinical validity classification was approved by the ClinGen Lysosomal Diseases GCEP on August 2, 2022 (SOP v9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/b1c19e4a-2e06-42d3-bdd6-72750aca2793","GCISnapshot":"https://genegraph.clinicalgenome.org/r/e88e0ef6-e788-40e2-bbd4-7fb3efb6b0ea","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/e88e0ef6-e788-40e2-bbd4-7fb3efb6b0ea_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10110","date":"2022-08-02T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/e88e0ef6-e788-40e2-bbd4-7fb3efb6b0ea_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10110","date":"2022-09-29T14:22:55.354Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e88e0ef6-e788-40e2-bbd4-7fb3efb6b0ea_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e88e0ef6-e788-40e2-bbd4-7fb3efb6b0ea_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b613824c-4d03-4109-8a11-68c7addb022f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9dc0edc7-a3e3-41cf-9c39-dd4bab4d2d66","type":"Finding","dc:description":"FUCA1 knockout mice show non-detectable alpha-fucosidase enzyme activity, systemic fucose accumulation, cytoplasmic vacuolization, and neurologic impairment (psychomotor and memory deficits), recapitulating key features of the human fucosidosis phenotype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27491075","rdfs:label":"FUCA1 knockout mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3903d5b6-6fb2-48c2-b3ef-315db990211f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/975f85a7-fb30-486f-bb2d-a67281543a57","type":"Finding","dc:description":"Hematopoietic stem cell transplantation (HSCT) resulted in progressive rise of alpha-fucosidase levels and improved psychomotor development, as measured by evaluation of evoked potentials and MRI (improved myelination and reduced atrophy, leading to near-normal appearance)\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11360116","rdfs:label":"HSC transplantation for fucosidosis","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/e88e0ef6-e788-40e2-bbd4-7fb3efb6b0ea_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50ee8ad8-fe9f-4d89-a524-24061ed11fac","type":"EvidenceLine","dc:description":"Per ClinGen LD GCEP guidelines, gene products that have a well-established function in a metabolic pathway are scored 2 points","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a86df85-7c92-4048-9d47-f588420150db","type":"Finding","dc:description":"FUCA1 encodes alpha-L-fucosidase, a lysosomal enzyme involved in the degradation of fucose-containing glycoproteins and glycolipids via cleaving via hydrolyzing alpha-fucose moieties at the non-reducing terminus of oligosaccharides (PMID: 2803312). \nPatients with fucosidosis have deficient alpha-L-fucosidase activity due to deficiency of functional alpha-L-fucosidase enzyme, resulting in systemic fucose accumulation in multiple tissues (PMID: 4172303, PMID: 4241464). \nThus, the biochemical function of the FUCA1 gene, i.e., its encoding the alpha-L-fucosidase enzyme, is consistent with the systemic fucose accumulation seen in fucosidosis. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/2803312","rdfs:label":"FUCA1 encodes alpha-fucosidase","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/e88e0ef6-e788-40e2-bbd4-7fb3efb6b0ea_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb9ea804-79c2-4fe6-8dea-5e42f937c0c0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5dadd443-e516-40fb-abbf-fa72858070c2","type":"EvidenceLine","dc:description":"Scored 0.75pts/variant to yield 1.5pts total and avoid double-counting for homozygous variant ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5dadd443-e516-40fb-abbf-fa72858070c2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8401503","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf9a0094-6909-42b9-a6fa-020e6ce4ce3d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000147.5(FUCA1):c.648C>A (p.Tyr216Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114442"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/eb9ea804-79c2-4fe6-8dea-5e42f937c0c0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8401503","rdfs:label":"Patient MB","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf9a0094-6909-42b9-a6fa-020e6ce4ce3d"},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/5dadd443-e516-40fb-abbf-fa72858070c2_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c044201e-810b-41da-a6df-9fd06fa1636d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3d760d7-5ef8-4583-8a8b-84d0db42496f","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3d760d7-5ef8-4583-8a8b-84d0db42496f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8401503","allele":{"id":"https://genegraph.clinicalgenome.org/r/3d5bd715-f8fa-4a37-8eb7-9b7953449be7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000147.5(FUCA1):c.1160G>A (p.Trp387Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114440"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/0118e19f-ed51-4ff8-940f-ffb1d6972f2b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0118e19f-ed51-4ff8-940f-ffb1d6972f2b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8401503","allele":{"id":"https://genegraph.clinicalgenome.org/r/7706c5b9-1bbd-4e55-b5d0-42bf53a7921b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000147.5(FUCA1):c.451del (p.Trp151GlyfsTer36)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573131871"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c044201e-810b-41da-a6df-9fd06fa1636d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8401503","rdfs:label":"Patient CS","allele":[{"id":"https://genegraph.clinicalgenome.org/r/7706c5b9-1bbd-4e55-b5d0-42bf53a7921b"},{"id":"https://genegraph.clinicalgenome.org/r/3d5bd715-f8fa-4a37-8eb7-9b7953449be7"}],"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0118e19f-ed51-4ff8-940f-ffb1d6972f2b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c3d760d7-5ef8-4583-8a8b-84d0db42496f_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/eed3bd0c-a023-47ef-8f0d-a44145cc3a08_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f6ef5fe7-c035-4825-9ee2-9dec8f3d3236","type":"EvidenceLine","dc:description":"Scored 0.75pts/variant to yield 1.5pts total and avoid double-counting for homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f6ef5fe7-c035-4825-9ee2-9dec8f3d3236_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9039984","allele":{"id":"https://genegraph.clinicalgenome.org/r/84fe80b8-3a8e-4ba5-9279-1a052b34fd4f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000147.5(FUCA1):c.340_349del (p.Phe114ArgfsTer16)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320210"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/eed3bd0c-a023-47ef-8f0d-a44145cc3a08","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9039984","rdfs:label":"Patient 1-Cragg","allele":{"id":"https://genegraph.clinicalgenome.org/r/84fe80b8-3a8e-4ba5-9279-1a052b34fd4f"},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/f6ef5fe7-c035-4825-9ee2-9dec8f3d3236_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a139ba85-ef0b-4f75-8246-bf340187cb1e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0d8f3d2-acb4-48c7-9497-1e551c2d8051","type":"EvidenceLine","dc:description":"Scored 0.75pts/variant to yield 1.5pts total and prevent double-counting for homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0d8f3d2-acb4-48c7-9497-1e551c2d8051_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8081399","allele":{"id":"https://genegraph.clinicalgenome.org/r/8c02b904-0a4f-4582-8da9-a57e0549606b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000147.5(FUCA1):c.758del (p.Ser253ThrfsTer8)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320211"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a139ba85-ef0b-4f75-8246-bf340187cb1e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8081399","rdfs:label":"Patient Ce","allele":{"id":"https://genegraph.clinicalgenome.org/r/8c02b904-0a4f-4582-8da9-a57e0549606b"},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e0d8f3d2-acb4-48c7-9497-1e551c2d8051_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2da4b5d8-2586-4314-9443-70697314726c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74eb1cc0-b25e-4a42-93d0-fe9eba58e3f4","type":"EvidenceLine","dc:description":"Scored 0.75pts per variant to yield 1.5pts total and prevent double-counting for homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74eb1cc0-b25e-4a42-93d0-fe9eba58e3f4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8097260","allele":{"id":"https://genegraph.clinicalgenome.org/r/503b34a0-8d47-4918-9862-6c4148b7f4c9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000147.5(FUCA1):c.969+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/684"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2da4b5d8-2586-4314-9443-70697314726c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8097260","rdfs:label":"Patient SB","allele":{"id":"https://genegraph.clinicalgenome.org/r/503b34a0-8d47-4918-9862-6c4148b7f4c9"},"detectionMethod":"Southern blot and SSCP analysis of PCR-amplified sequences of the FUCA1 gene, followed by Sanger sequencing","firstTestingMethod":"Other","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/74eb1cc0-b25e-4a42-93d0-fe9eba58e3f4_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/4524d582-0321-41cf-8cac-399fea069311_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/674a780c-38ef-4956-9b1a-430d174e1930","type":"EvidenceLine","dc:description":"Score 0.75pts per variant to yield 1.5pts total and prevent double-counting for homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/674a780c-38ef-4956-9b1a-430d174e1930_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1281988","allele":{"id":"https://genegraph.clinicalgenome.org/r/9db501bf-274d-4d42-88f7-5ac9f9e40681","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000147.5(FUCA1):c.1138G>T (p.Glu380Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114436"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/4524d582-0321-41cf-8cac-399fea069311","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1281988","rdfs:label":"Patient JT","allele":{"id":"https://genegraph.clinicalgenome.org/r/9db501bf-274d-4d42-88f7-5ac9f9e40681"},"detectionMethod":"cDNA was prepared from alpha-L-fucosidase mRNA of JT and each cDNA was amplified by the polymerase chain reaction.","firstTestingMethod":"PCR","previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/674a780c-38ef-4956-9b1a-430d174e1930_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/af6a7f5f-d50c-4d3e-bc13-b886edc9b33f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d670ecfb-c953-4b90-a595-f117d181615a","type":"EvidenceLine","dc:description":"Scored 1pt per variant to yield 2pts total and prevent double-counting for homozygous variant ","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d670ecfb-c953-4b90-a595-f117d181615a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 2803224: Patient cell lines harboring the variant in the homozygous state show reduced alpha-fucosidase catalytic activity and extracellular release of alpha-fucosidase versus cells with wild-type FUCA1","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d670ecfb-c953-4b90-a595-f117d181615a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/2642067","allele":{"id":"https://genegraph.clinicalgenome.org/r/1d50e562-49d0-4e88-9f34-f5a735cf8dc8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000147.5(FUCA1):c.1279C>T (p.Gln427Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114434"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/af6a7f5f-d50c-4d3e-bc13-b886edc9b33f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/2642067","rdfs:label":"Patient RP","allele":{"id":"https://genegraph.clinicalgenome.org/r/1d50e562-49d0-4e88-9f34-f5a735cf8dc8"},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Restriction digest","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d670ecfb-c953-4b90-a595-f117d181615a_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":5087,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/o0k38OzAMNM","type":"GeneValidityProposition","disease":"obo:MONDO_0009254","gene":"hgnc:4006","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_e88e0ef6-e788-40e2-bbd4-7fb3efb6b0ea-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}